SARS-CoV-2: An Updated Review Highlighting Its Evolution and Treatments

Since the SARS-CoV-2 outbreak, pharmaceutical companies and researchers worldwide have worked hard to develop vaccines and drugs to end the SARS-CoV-2 pandemic. The potential pathogen responsible for Coronavirus Disease 2019 (COVID-19), SARS-CoV-2, belongs to a novel lineage of beta coronaviruses in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xirui, Yuan, Hao, Yang, Zipeng, Hu, Xiaoyu, Mahmmod, Yasser S., Zhu, Xiaojing, Zhao, Cuiping, Zhai, Jingbo, Zhang, Xiu-Xiang, Luo, Shengjun, Wang, Xiao-Hu, Xue, Mengzhou, Zheng, Chunfu, Yuan, Zi-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780920/
https://www.ncbi.nlm.nih.gov/pubmed/36560555
http://dx.doi.org/10.3390/vaccines10122145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780920/
https://www.ncbi.nlm.nih.gov/pubmed/36560555
http://dx.doi.org/10.3390/vaccines10122145

Ejemplares similares